{"hands_on_practices": [{"introduction": "Autonomic dysfunction is a core supportive feature in the diagnosis of major neurocognitive disorder with Lewy bodies. This problem, [@problem_id:4722174], provides practice in quantifying one of its most common manifestations: orthostatic hypotension. By applying the specific consensus criteria to a hypothetical patient's blood pressure readings, you will translate raw clinical data into a formal diagnostic finding, a crucial skill for accurate assessment.", "problem": "A patient diagnosed with Lewy body neurocognitive disorder (also termed major neurocognitive disorder with Lewy bodies) presents with lightheadedness on standing. In Lewy body neurocognitive disorder, autonomic nervous system dysfunction impairs baroreflex-mediated vascular responses, predisposing to orthostatic hypotension. Orthostatic hypotension (OH) is operationally defined, by widely used consensus criteria, as a decrease in systolic blood pressure (BP) of at least $20$ millimeters of mercury (mmHg) or a decrease in diastolic BP of at least $10$ mmHg measured within $3$ minutes of standing from supine rest.\n\nAfter $5$ minutes supine rest, the patientâ€™s supine systolic BP is $140$ mmHg and supine diastolic BP is $80$ mmHg. At $3$ minutes after standing, the systolic BP is $110$ mmHg and the diastolic BP is $70$ mmHg.\n\nUsing the consensus definition above and taking the orthostatic drops as $\\Delta SBP = SBP_{\\text{supine}} - SBP_{\\text{standing}}$ and $\\Delta DBP = DBP_{\\text{supine}} - DBP_{\\text{standing}}$, compute the indicator function\n$$I = \\begin{cases}\n1, & \\text{if } \\Delta SBP \\ge 20 \\text{ or } \\Delta DBP \\ge 10 \\\\\n0, & \\text{otherwise}\n\\end{cases}$$\nfor this patient at $3$ minutes. Report the value of $I$ as the final answer. No rounding is required. Do not include units in the final answer.", "solution": "Lewy body neurocognitive disorder is characterized by central and peripheral autonomic nervous system dysfunction, including impaired baroreflex responses. Normally, upon standing, venous pooling reduces venous return, transiently lowering stroke volume and arterial pressure; intact baroreflexes increase heart rate and peripheral vascular resistance to counteract this. In autonomic failure, these compensations are blunted, leading to sustained orthostatic reductions in blood pressure.\n\nThe consensus operational definition of orthostatic hypotension (OH) states that within $3$ minutes of standing, there is OH if either the systolic blood pressure decreases by at least $20$ mmHg or the diastolic blood pressure decreases by at least $10$ mmHg compared to the supine measurement.\n\nWe compute the orthostatic drops from the given values:\n- Supine systolic blood pressure $SBP_{\\text{supine}} = 140$ mmHg; standing systolic blood pressure at $3$ minutes $SBP_{\\text{standing}} = 110$ mmHg. Thus,\n$$\\Delta SBP = SBP_{\\text{supine}} - SBP_{\\text{standing}} = 140 - 110 = 30.$$\n- Supine diastolic blood pressure $DBP_{\\text{supine}} = 80$ mmHg; standing diastolic blood pressure at $3$ minutes $DBP_{\\text{standing}} = 70$ mmHg. Thus,\n$$\\Delta DBP = DBP_{\\text{supine}} - DBP_{\\text{standing}} = 80 - 70 = 10.$$\n\nWe now evaluate the indicator function:\n$$I = \\begin{cases}\n1, & \\text{if } \\Delta SBP \\ge 20 \\text{ or } \\Delta DBP \\ge 10 \\\\\n0, & \\text{otherwise}\n\\end{cases}.$$\n\nHere, $\\Delta SBP = 30 \\ge 20$ is true, and $\\Delta DBP = 10 \\ge 10$ is also true. Therefore, the condition for OH is satisfied. Hence,\n$$I = 1.$$", "answer": "$$\\boxed{1}$$", "id": "4722174"}, {"introduction": "Dopamine transporter (DaT) SPECT imaging is a valuable tool for increasing diagnostic certainty in suspected Lewy body neurocognitive disorder. This exercise [@problem_id:4722130] moves beyond a simple \"positive\" or \"negative\" test result to demonstrate the power of Bayesian updating in clinical practice. You will learn to use a test's positive likelihood ratio ($LR_+$) to formally calculate how a test result transforms a pre-test probability into a more definitive posterior probability, a core skill in evidence-based diagnosis.", "problem": "A patient with fluctuating attention, recurrent formed visual hallucinations, and spontaneous parkinsonism consistent with a suspected diagnosis of Lewy body neurocognitive disorder presents for further evaluation. Based on the clinical features and course, the pre-test probability is estimated as $p_{\\text{prior}}=0.30$. The patient undergoes dopamine transporter single-photon emission computed tomography (SPECT) imaging using iodine-123 ioflupane, commonly referred to as a DaTscan, and the result is positive. A recent meta-analysis reports a positive likelihood ratio defined by $LR_{+}=\\frac{\\text{sensitivity}}{1-\\text{specificity}}$ of $LR_{+}=5$ for a positive DaTscan in differentiating Lewy body neurocognitive disorder from Alzheimer-type presentations.\n\nStarting from Bayes theorem and the odds form of updating, derive the posterior probability of Lewy body neurocognitive disorder given the positive DaTscan, and compute its numerical value. Express your final numeric answer as a decimal rounded to $4$ significant figures. No units are required. In addition, briefly explain, based on test characteristics and clinical thresholds, how this posterior probability alters diagnostic confidence and decision-making for Lewy body neurocognitive disorder without making any treatment recommendations.", "solution": "The problem is valid as it is scientifically grounded in Bayesian statistics and its application to medical diagnostics, is well-posed with sufficient information for a unique solution, and is expressed in objective, formal language. We may proceed with the solution.\n\nLet $D$ be the event that the patient has Lewy body neurocognitive disorder, and let $T_+$ be the event that the patient has a positive DaTscan result.\n\nWe are given the following information:\nThe pre-test probability, or prior probability, is $P(D) = p_{\\text{prior}} = 0.30$.\nThe positive likelihood ratio is $LR_{+} = 5$.\n\nThe task is to find the posterior probability, $P(D|T_+)$, which is the probability of the disorder given the positive test result. We will use the odds form of Bayes' theorem as requested.\n\nThe odds of an event $A$ are defined as the ratio of the probability of the event occurring to the probability of the event not occurring, $O(A) = \\frac{P(A)}{1 - P(A)}$.\n\nFirst, we calculate the prior odds of having the disorder, $\\text{Odds}_{\\text{prior}}(D)$:\n$$\n\\text{Odds}_{\\text{prior}}(D) = \\frac{P(D)}{1 - P(D)} = \\frac{0.30}{1 - 0.30} = \\frac{0.30}{0.70} = \\frac{3}{7}\n$$\n\nThe odds form of Bayes' theorem states that the posterior odds are the product of the prior odds and the likelihood ratio. Let us derive this relationship.\nThe posterior odds are given by $\\text{Odds}_{\\text{posterior}}(D|T_+) = \\frac{P(D|T_+)}{P(D^c|T_+)}$, where $D^c$ is the complement of $D$.\n\nUsing Bayes' theorem, we have:\n$$\nP(D|T_+) = \\frac{P(T_+|D)P(D)}{P(T_+)}\n$$\n$$\nP(D^c|T_+) = \\frac{P(T_+|D^c)P(D^c)}{P(T_+)}\n$$\n\nDividing these two expressions gives the posterior odds:\n$$\n\\text{Odds}_{\\text{posterior}}(D|T_+) = \\frac{P(D|T_+)}{P(D^c|T_+)} = \\frac{P(T_+|D)P(D)/P(T_+)}{P(T_+|D^c)P(D^c)/P(T_+)} = \\frac{P(T_+|D)P(D)}{P(T_+|D^c)P(D^c)}\n$$\nRearranging the terms, we get:\n$$\n\\text{Odds}_{\\text{posterior}}(D|T_+) = \\left(\\frac{P(T_+|D)}{P(T_+|D^c)}\\right) \\left(\\frac{P(D)}{P(D^c)}\\right)\n$$\nThe first term is the definition of the positive likelihood ratio, $LR_+$. The problem states that $LR_{+} = \\frac{\\text{sensitivity}}{1-\\text{specificity}} = \\frac{P(T_+|D)}{P(T_+|D^c)}$. The second term is the definition of the prior odds. Thus, we have derived the required relationship:\n$$\n\\text{Odds}_{\\text{posterior}} = LR_{+} \\times \\text{Odds}_{\\text{prior}}\n$$\n\nNow, we can calculate the posterior odds for the patient:\n$$\n\\text{Odds}_{\\text{posterior}} = 5 \\times \\frac{3}{7} = \\frac{15}{7}\n$$\n\nFinally, we convert the posterior odds back to the posterior probability, $p_{\\text{post}} = P(D|T_+)$. The relationship between probability $p$ and odds $O$ is $p = \\frac{O}{1+O}$.\n$$\np_{\\text{post}} = P(D|T_+) = \\frac{\\text{Odds}_{\\text{posterior}}}{1 + \\text{Odds}_{\\text{posterior}}} = \\frac{15/7}{1 + 15/7} = \\frac{15/7}{(7+15)/7} = \\frac{15/7}{22/7} = \\frac{15}{22}\n$$\n\nTo obtain the numerical value, we perform the division:\n$$\n\\frac{15}{22} \\approx 0.681818...\n$$\nRounding to $4$ significant figures, the posterior probability is $0.6818$.\n\nRegarding the clinical implications, the pre-test probability of Lewy body neurocognitive disorder was $p_{\\text{prior}} = 0.30$, or a $30\\%$ chance. This represents a moderate clinical suspicion based on symptoms but carries significant diagnostic uncertainty. After the positive DaTscan, the posterior probability has increased to $p_{\\text{post}} \\approx 0.6818$, or approximately $68\\%$. This more than doubling of the probability substantially alters diagnostic confidence. A probability of nearly $70\\%$ is often sufficient to cross a \"diagnostic threshold,\" allowing the clinician to establish a working diagnosis with much greater certainty. This increased confidence directly influences decision-making by justifying a management plan tailored to Lewy body neurocognitive disorder, which can have different prognostic and therapeutic considerations than its common mimics like Alzheimer's disease. For example, it provides a stronger rationale for initiating specific pharmacotherapies and for counseling the patient and family about the expected disease course. However, it is crucial to recognize that a probability of $68\\%$ is not certainty; there remains a non-trivial chance (approximately $32\\%$) that the diagnosis is incorrect (i.e., a false positive result), and ongoing clinical monitoring remains essential.", "answer": "$$\n\\boxed{0.6818}\n$$", "id": "4722130"}, {"introduction": "After establishing a diagnosis, the focus of care often shifts to managing burdensome symptoms such as psychosis. This practice [@problem_id:4722156] challenges you to think like a clinical epidemiologist by evaluating data from a hypothetical randomized controlled trial. By calculating the Absolute Risk Reduction ($ARR$) and the Number Needed to Treat ($NNT$), you will learn to translate statistical outcomes from a research paper into clinically intuitive metrics that inform therapeutic decision-making and patient counseling.", "problem": "A double-blind, randomized controlled trial evaluated pimavanserin, a selective serotonin 5-hydroxytryptamine-2A receptor inverse agonist, for psychosis in Dementia with Lewy Bodies (DLB). Participants met consensus clinical criteria for probable Dementia with Lewy Bodies (DLB) with persistent visual hallucinations and/or delusions. The prespecified primary clinical response was defined as a clinically meaningful improvement in psychosis by a validated scale sustained without motor deterioration. At the primary endpoint, the observed response probability was $55\\%$ in the pimavanserin arm and $35\\%$ in the placebo arm.\n\nUsing only fundamental definitions from clinical epidemiology about risk and treatment effects, compute:\n- the absolute risk reduction (expressed as a decimal proportion, not with a percent sign), and\n- the Number Needed to Treat (NNT) to achieve one additional clinical response with pimavanserin rather than placebo.\n\nReport both values in the order absolute risk reduction, then NNT. Express the absolute risk reduction as a decimal and the NNT as an exact integer. No rounding is required. Do not include any units in your final reported values.", "solution": "The problem is first validated to ensure it is scientifically grounded, well-posed, and objective.\n\n**Step 1: Extract Givens**\n- Trial Design: Double-blind, randomized controlled trial.\n- Intervention: Pimavanserin.\n- Control: Placebo.\n- Population: Patients with probable Dementia with Lewy Bodies (DLB) experiencing psychosis.\n- Primary Outcome: A sustained, clinically meaningful improvement in psychosis without motor deterioration.\n- Probability of response in the pimavanserin arm ($P_{\\text{exp}}$): $55\\%$.\n- Probability of response in the placebo arm ($P_{\\text{ctrl}}$): $35\\%$.\n\n**Step 2: Validate Using Extracted Givens**\nThe problem is deemed valid.\n- **Scientifically Grounded:** The problem describes a standard clinical trial scenario and uses established, fundamental concepts from clinical epidemiology (response probability, absolute risk reduction, number needed to treat). The context of psychosis in Dementia with Lewy Bodies and the use of a selective serotonin receptor inverse agonist are scientifically sound and relevant to modern neuropsychiatry.\n- **Well-Posed:** All necessary data for the calculations are provided. The definitions for the quantities to be calculated (Absolute Risk Reduction and Number Needed to Treat) are standard and unambiguous, leading to a unique and meaningful solution.\n- **Objective:** The problem statement is presented using factual, quantitative, and unbiased language.\n\n**Step 3: Verdict and Action**\nThe problem is valid. A complete solution will be provided.\n\n**Solution Derivation**\n\nThe problem requires the calculation of two key metrics from clinical epidemiology: the Absolute Risk Reduction (ARR) and the Number Needed to Treat (NNT).\n\nLet $P_{\\text{exp}}$ be the probability of the desired clinical outcome (response) in the experimental group (pimavanserin). Let $P_{\\text{ctrl}}$ be the probability of the same outcome in the control group (placebo).\n\nFrom the problem statement, we have:\n$$P_{\\text{exp}} = 55\\% = 0.55$$\n$$P_{\\text{ctrl}} = 35\\% = 0.35$$\n\nThe Absolute Risk Reduction (ARR) is defined as the absolute difference between the event rate in the control group and the event rate in the experimental group. When the \"event\" is a desirable outcome, as in this case (a clinical response), this quantity is also known as the Absolute Benefit Increase (ABI). The formula is:\n$$ARR = P_{\\text{exp}} - P_{\\text{ctrl}}$$\n\nSubstituting the given values into the formula:\n$$ARR = 0.55 - 0.35 = 0.20$$\nThe problem requests this value as a decimal proportion, which is $0.20$.\n\nThe Number Needed to Treat (NNT) is the average number of patients who need to be treated with the experimental intervention to prevent one additional bad outcome or, as in this case, to achieve one additional good outcome. It is the reciprocal of the Absolute Risk Reduction.\n$$NNT = \\frac{1}{ARR}$$\n\nUsing the calculated value of ARR:\n$$NNT = \\frac{1}{0.20}$$\nTo compute the exact integer value, we can express the decimal as a fraction.\n$$0.20 = \\frac{20}{100} = \\frac{1}{5}$$\nTherefore, the NNT is:\n$$NNT = \\frac{1}{\\frac{1}{5}} = 5$$\nThe NNT is $5$. This means that, on average, $5$ patients with DLB-related psychosis must be treated with pimavanserin for one additional patient to achieve a clinical response who would not have done so on placebo.\n\nThe final values are an absolute risk reduction of $0.20$ and a number needed to treat of $5$.", "answer": "$$\\boxed{\\begin{pmatrix} 0.20 & 5 \\end{pmatrix}}$$", "id": "4722156"}]}